Does research synthesis have a place in drug regulatory policy? Synopsis of issues: Assessment of efficacy and drug approval

Clinical Research and Regulatory Affairs

Volumn 13, Issue 1, 1996, Pages 23-29

  O'Neill, Robert T ^a   Anello, Charles ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL RESEARCH; CONFERENCE PAPER; DRUG EFFICACY; DRUG LEGISLATION; DRUG RESEARCH; DRUG SAFETY; DRUG SCREENING; FOOD AND DRUG ADMINISTRATION; METHODOLOGY;

EID: 0029966554     PISSN: 10601333     EISSN: None     Source Type: Journal    
DOI: 10.3109/10601339609019626     Document Type: Conference Paper

References (2)

1. Lindsay, M.R., Ehrenberg, A.S.C.. The Design of Replicated Studies. The American Statistician, 47, 217-228 (1993).
2. Goodman, S.N. A Comment on Replication, P-values and Evidence. Stat Med,11, 875-879 (1992).